CryoPort
Open
$14.58
Prev. Close
$14.58
High
$14.64
Low
$14.58
Market Snapshot
$728.9M
10.7
-2.49
$174.85M
688
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. The company is headquartered in Brentwood, Tennessee and currently employs 684 full-time employees. The company went IPO on 2015-07-24. The firm operates through two segments: segments: Life Sciences Services and Life Sciences Products. Its life sciences services include BioLogistics and BioStorage/BioServices, which provides temperature-controlled logistics, biostorage and bioservices within the life science industry through direct sales. Its life sciences products segment manufactures and sells cryogenic systems, such as freezers and cryogenic dewars and related ancillary accessories used in the storage and transport of life science commodities through direct sales or a distribution network. Its operating units include Cryoport Systems, CryoGene and MVE Biological Solutions (MVE). Cryoport Systems provides temperature-controlled BioLogistics, BioServices, and cryopreservation solutions, supporting clinical and commercial workflows through transport, kit production, labeling, packaging, and others.
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. The company is headquartered in Brentwood, Tennessee and currently employs 684 full-time employees. The company went IPO on 2015-07-24. The firm operates through two segments: segments: Life Sciences Services and Life Sciences Products. Its life sciences services include BioLogistics and BioStorage/BioServices, which provides temperature-controlled logistics, biostorage and bioservices within the life science industry through direct sales. Its life sciences products segment manufactures and sells cryogenic systems, such as freezers and cryogenic dewars and related ancillary accessories used in the storage and transport of life science commodities through direct sales or a distribution network. Its operating units include Cryoport Systems, CryoGene and MVE Biological Solutions (MVE). Cryoport Systems provides temperature-controlled BioLogistics, BioServices, and cryopreservation solutions, supporting clinical and commercial workflows through transport, kit production, labeling, packaging, and others.
Recently from Cashu
CryoPort Reports 25% Revenue Growth Amid Rising Demand for Temperature-Controlled Logistics Solutions
CryoPort Sees Strong Revenue Growth Driven by Demand for Temperature-Controlled Supply Chain Solutions CryoPort, Inc. demonstrates robust growth in its recent Q4 earnings report, highlighting a 25% ye…
CryoPort Reports 25% Revenue Growth and Positive Outlook in Q4 Earnings for 2026
### CryoPort’s Q4 Earnings Showcase Robust Growth and Strategic Investments CryoPort, Inc. reports a remarkable performance in its Q4 earnings for 2026, with a significant revenue growth of 25% year-o…
Anticipation Grows for CryoPort's Earnings Amid Biopharmaceutical Sector's Rising Demand
CryoPort Prepares for Key Earnings Announcement Amidst Biopharmaceutical Sector Growth As CryoPort approaches its quarterly earnings announcement scheduled for March 3, 2026, stakeholders are keenly a…
CryoPort Set to Announce Key Earnings Amid Biopharmaceutical Sector Growth and Challenges
CryoPort Prepares for Impactful Earnings Release Amid Biopharmaceutical Growth As CryoPort approaches its scheduled quarterly earnings announcement on March 3, 2026, anticipation builds around the com…